Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Time to Treatment Intensification in Newly Treated Adult Type 2 Diabetes Patients: Comparison of Canada and the United States.

Dubois TB, Simpson SH, Eurich DT.

Can J Diabetes. 2019 Sep 25. pii: S1499-2671(19)30657-4. doi: 10.1016/j.jcjd.2019.09.002. [Epub ahead of print]

PMID:
31831258
2.

Costarting sitagliptin with metformin is associated with a lower likelihood of disease progression in newly treated people with type 2 diabetes: a cohort study.

Campbell SA, Light PE, Simpson SH.

Diabet Med. 2019 Oct 16. doi: 10.1111/dme.14154. [Epub ahead of print]

PMID:
31618475
3.

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study.

Sharma V, Weir D, Samanani S, Simpson SH, Gilani F, Jess E, Eurich DT.

BMJ Open. 2019 Sep 6;9(9):e030858. doi: 10.1136/bmjopen-2019-030858.

4.

Factors associated with pneumococcal vaccination in 2040 people with type 2 diabetes: A cross-sectional study.

Gilani F, Majumdar SR, Johnson JA, Simpson SH; ABCD Cohort Investigators.

Diabetes Metab. 2019 Jun 27. pii: S1262-3636(19)30094-1. doi: 10.1016/j.diabet.2019.06.003. [Epub ahead of print]

PMID:
31255692
5.

Evaluation of Healthy User Effects With Metformin and Other Oral Antihyperglycemia Medication Users in Adult Patients With Type 2 Diabetes.

Eskin M, Simpson SH, Eurich DT.

Can J Diabetes. 2019 Jul;43(5):322-328. doi: 10.1016/j.jcjd.2018.12.001. Epub 2018 Dec 13.

PMID:
30782471
6.

Transverse spin forces and non-equilibrium particle dynamics in a circularly polarized vacuum optical trap.

Svak V, Brzobohatý O, Šiler M, Jákl P, Kaňka J, Zemánek P, Simpson SH.

Nat Commun. 2018 Dec 21;9(1):5453. doi: 10.1038/s41467-018-07866-8.

7.

Optical Trapping, Optical Binding, and Rotational Dynamics of Silicon Nanowires in Counter-Propagating Beams.

Donato MG, Brzobohatý O, Simpson SH, Irrera A, Leonardi AA, Lo Faro MJ, Svak V, Maragò OM, Zemánek P.

Nano Lett. 2019 Jan 9;19(1):342-352. doi: 10.1021/acs.nanolett.8b03978. Epub 2018 Dec 12.

PMID:
30525673
8.

Knowledge of a Diabetes Risk Score Does Not Alter Diabetes Screening Practice in a Seniors Population: A Randomized Controlled Trial.

Law V, Featherstone T, Eurich DT, Simpson SH.

J Am Med Dir Assoc. 2018 Nov;19(11):1021-1023. doi: 10.1016/j.jamda.2018.06.001. Epub 2018 Jul 23. No abstract available.

PMID:
30049541
9.

Impact of Drug Exposure Definitions on Observed Associations in Pharmacoepidemiology Research.

Eskin M, Eurich DT, Simpson SH.

J Popul Ther Clin Pharmacol. 2018 Mar 20;25(1):e39-e52. doi: 10.22374/1710-6222.25.1.4.

PMID:
29949683
10.

Pharmacy Practice and Diabetes Care.

Simpson SH, MacCallum L, Mansell K.

Can J Diabetes. 2017 Dec;41(6):549-550. doi: 10.1016/j.jcjd.2017.09.005. No abstract available.

PMID:
29224632
11.

Provincial Comparison of Pharmacist Prescribing in Canada Using Alberta's Model as the Reference Point.

Bhatia S, Simpson SH, Bungard T.

Can J Hosp Pharm. 2017 Sep-Oct;70(5):349-357. Epub 2017 Oct 31.

12.

Optical Binding of Nanowires.

Simpson SH, Zemánek P, Maragò OM, Jones PH, Hanna S.

Nano Lett. 2017 Jun 14;17(6):3485-3492. doi: 10.1021/acs.nanolett.7b00494. Epub 2017 May 31.

PMID:
28535340
13.

Community Pharmacy-Based Inducement Programs Associated With Better Medication Adherence: A Cohort Study.

Simpson SH, Lin M, Eurich DT.

Ann Pharmacother. 2017 Aug;51(8):630-639. doi: 10.1177/1060028017703720. Epub 2017 Apr 3.

PMID:
28372491
14.

Nos rôles à titre de pharmaciens d’hôpitaux.

Simpson SH.

Can J Hosp Pharm. 2017 Jan-Feb;70(1):5-6. Epub 2017 Feb 28. French. No abstract available.

PMID:
28348426
Free PMC Article
15.

The Roles We Have as Hospital Pharmacists.

Simpson SH.

Can J Hosp Pharm. 2017 Jan-Feb;70(1):3-4. Epub 2017 Feb 28. No abstract available.

16.

Limited Effectiveness of Diabetes Risk Assessment Tools in Seniors' Facility Residents.

Featherstone T, Eurich DT, Simpson SH.

Value Health. 2017 Mar;20(3):329-335. doi: 10.1016/j.jval.2016.09.2403. Epub 2016 Nov 11.

17.

Financial remuneration is positively correlated with the number of clinical activities: an example from diabetes management in Alberta community pharmacies.

Bharadia R, Lorenz K, Cor K, Simpson SH.

Int J Pharm Pract. 2018 Feb;26(1):77-80. doi: 10.1111/ijpp.12331. Epub 2017 Feb 27.

PMID:
28240395
18.

Factors Affecting Number of Diabetes Management Activities Provided by Pharmacists.

Lo A, Lorenz K, Cor K, Simpson SH.

Can J Diabetes. 2016 Dec;40(6):535-542. doi: 10.1016/j.jcjd.2016.05.003. Epub 2016 Jun 30.

PMID:
27373434
19.

Medication Adherence Affects Risk of New Diabetes Complications: A Cohort Study.

Simpson SH, Lin M, Eurich DT.

Ann Pharmacother. 2016 Sep;50(9):741-6. doi: 10.1177/1060028016653609. Epub 2016 Jun 15.

PMID:
27307411
20.

Photonic Torque Microscopy of the Nonconservative Force Field for Optically Trapped Silicon Nanowires.

Irrera A, Magazzù A, Artoni P, Simpson SH, Hanna S, Jones PH, Priolo F, Gucciardi PG, Maragò OM.

Nano Lett. 2016 Jul 13;16(7):4181-8. doi: 10.1021/acs.nanolett.6b01059. Epub 2016 Jun 13.

PMID:
27280642
21.

Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes.

Abdelmoneim AS, Eurich DT, Senthilselvan A, Qiu W, Simpson SH.

Pharmacoepidemiol Drug Saf. 2016 Oct;25(10):1186-1195. doi: 10.1002/pds.4014. Epub 2016 Apr 22.

PMID:
27102581
22.

A Pilot Trial of a Sexual Health Counseling Intervention for HIV-Positive Gay and Bisexual Men Who Report Anal Sex without Condoms.

Hart TA, Stratton N, Coleman TA, Wilson HA, Simpson SH, Julien RE, Hoe D, Leahy B, Maxwell J, Adam BD.

PLoS One. 2016 Apr 7;11(4):e0152762. doi: 10.1371/journal.pone.0152762. eCollection 2016.

23.

Precise, contactless measurements of the surface tension of picolitre aerosol droplets.

Bzdek BR, Power RM, Simpson SH, Reid JP, Royall CP.

Chem Sci. 2016 Jan 1;7(1):274-285. doi: 10.1039/c5sc03184b. Epub 2015 Oct 5.

24.

'Lissajous-like' trajectories in optical tweezers.

Hay RF, Gibson GM, Simpson SH, Padgett MJ, Phillips DB.

Opt Express. 2015 Dec 14;23(25):31716-27. doi: 10.1364/OE.23.031716.

PMID:
26698964
25.

Mass-manufacturable polymer microfluidic device for dual fiber optical trapping.

De Coster D, Ottevaere H, Vervaeke M, Van Erps J, Callewaert M, Wuytens P, Simpson SH, Hanna S, De Malsche W, Thienpont H.

Opt Express. 2015 Nov 30;23(24):30991-1009. doi: 10.1364/OE.23.030991.

PMID:
26698730
26.

Sulfonylurea use is associated with larger infarct size in patients with diabetes and ST-elevation myocardial infarction.

Abdelmoneim AS, Welsh RC, Eurich DT, Simpson SH.

Int J Cardiol. 2016 Jan 1;202:126-30. doi: 10.1016/j.ijcard.2015.08.213. Epub 2015 Sep 1.

PMID:
26386939
27.

Creating a Data Analysis Plan: What to Consider When Choosing Statistics for a Study.

Simpson SH.

Can J Hosp Pharm. 2015 Jul-Aug;68(4):311-7. No abstract available.

28.

Risk of new-onset heart failure in patients using sitagliptin: a population-based cohort study.

Eurich DT, Weir DL, Simpson SH, Senthilselvan A, McAlister FA.

Diabet Med. 2016 May;33(5):621-30. doi: 10.1111/dme.12867. Epub 2015 Aug 25.

PMID:
26206341
29.

L'intégration des nouvelles données probantes dans la pratique et la nécessité de l'application des connaissances.

Simpson SH.

Can J Hosp Pharm. 2015 Mar-Apr;68(2):102-3. French. No abstract available.

30.

Applying new evidence into practice: a need for knowledge translation.

Simpson SH.

Can J Hosp Pharm. 2015 Mar-Apr;68(2):100-1. No abstract available.

31.

Pharmacists on primary care teams: Effect on antihypertensive medication management in patients with type 2 diabetes.

Omran D, Majumdar SR, Johnson JA, Tsuyuki RT, Lewanczuk RZ, Guirguis LM, Makowsky M, Simpson SH.

J Am Pharm Assoc (2003). 2015 May-Jun;55(3):265-8. doi: 10.1331/JAPhA.2015.14225.

PMID:
25909463
32.

Transitional behavior in hydrodynamically coupled oscillators.

Box S, Debono L, Phillips DB, Simpson SH.

Phys Rev E Stat Nonlin Soft Matter Phys. 2015 Feb;91(2):022916. Epub 2015 Feb 17.

PMID:
25768578
33.
34.

Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer.

Abdelmoneim AS, Eurich DT, Light PE, Senior PA, Seubert JM, Makowsky MJ, Simpson SH.

Diabetes Obes Metab. 2015 Jun;17(6):523-532. doi: 10.1111/dom.12456. Epub 2015 Mar 20. Review.

PMID:
25711240
35.

Limited impact of drug exposure misclassification from non-benefit thiazolidinedione drug use on mortality and hospitalizations from Saskatchewan, Canada: a cohort study.

Gamble JM, Johnson JA, McAlister FA, Majumdar SR, Simpson SH, Eurich DT.

Clin Ther. 2015 Mar 1;37(3):629-42. doi: 10.1016/j.clinthera.2014.12.014. Epub 2015 Jan 14.

PMID:
25596665
36.

Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial.

Simpson SH, Lier DA, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA.

Diabet Med. 2015 Jul;32(7):899-906. doi: 10.1111/dme.12692. Epub 2015 Feb 2.

PMID:
25594919
37.

Comparative cardiovascular safety of insulin secretagogues following hospitalization for ischemic heart disease among type 2 diabetes patients: a cohort study.

Huang Y, Abdelmoneim AS, Light P, Qiu W, Simpson SH.

J Diabetes Complications. 2015 Mar;29(2):196-202. doi: 10.1016/j.jdiacomp.2014.11.012. Epub 2014 Dec 2.

PMID:
25534984
38.

Mortality risk among sulfonylureas: a systematic review and network meta-analysis.

Simpson SH, Lee J, Choi S, Vandermeer B, Abdelmoneim AS, Featherstone TR.

Lancet Diabetes Endocrinol. 2015 Jan;3(1):43-51. doi: 10.1016/S2213-8587(14)70213-X. Epub 2014 Oct 22.

PMID:
25466239
39.

Sex-based disparities in cardioprotective medication use in adults with diabetes.

Butalia S, Lewin AM, Simpson SH, Dasgupta K, Khan N, Pilote L, Johnson JA, Ghali WA, Rabi DM.

Diabetol Metab Syndr. 2014 Nov 5;6(1):117. doi: 10.1186/1758-5996-6-117. eCollection 2014.

40.

Clinical and pathologic features of familial pancreatic cancer.

Humphris JL, Johns AL, Simpson SH, Cowley MJ, Pajic M, Chang DK, Nagrial AM, Chin VT, Chantrill LA, Pinese M, Mead RS, Gill AJ, Samra JS, Kench JG, Musgrove EA, Tucker KM, Spigelman AD, Waddell N, Grimmond SM, Biankin AV; Australian Pancreatic Cancer Genome Initiative.

Cancer. 2014 Dec 1;120(23):3669-75. doi: 10.1002/cncr.28863. Epub 2014 Oct 14.

41.

Returning individual research results for genome sequences of pancreatic cancer.

Johns AL, Miller DK, Simpson SH, Gill AJ, Kassahn KS, Humphris JL, Samra JS, Tucker K, Andrews L, Chang DK, Waddell N, Pajic M, Pearson JV, Grimmond SM, Biankin AV, Zeps N.

Genome Med. 2014 May 29;6(5):42. doi: 10.1186/gm558. eCollection 2014.

42.

Feasibility of a self-administered survey to identify primary care patients at risk of medication-related problems.

Makowsky MJ, Cave AJ, Simpson SH.

J Multidiscip Healthc. 2014 Feb 22;7:123-7. doi: 10.2147/JMDH.S46910. eCollection 2014.

43.

Prevalence of high on-treatment platelet reactivity in diabetic patients treated with aspirin.

Simpson SH, Abdelmoneim AS, Omran D, Featherstone TR.

Am J Med. 2014 Jan;127(1):95.e1-9. doi: 10.1016/j.amjmed.2013.09.019. Epub 2013 Oct 8. Review.

PMID:
24384107
44.

Use patterns of antidiabetic regimens by patients with type 2 diabetes.

Abdelmoneim AS, Eurich DT, Gamble JM, Simpson SH.

Can J Diabetes. 2013 Dec;37(6):394-400. doi: 10.1016/j.jcjd.2013.04.008.

PMID:
24321720
45.

Changes in thiazolidinedione use and outcomes following removal of a prior-authorization policy: controlled time-series analysis.

Gamble JM, Majumdar SR, Johnson JA, McAlister FA, Simpson SH, Eurich DT.

Med Care. 2014 Jan;52(1):47-55. doi: 10.1097/MLR.0000000000000006.

PMID:
24309670
46.

Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study.

Abdelmoneim AS, Eurich DT, Gamble JM, Johnson JA, Seubert JM, Qiu W, Simpson SH.

Diabetes Obes Metab. 2014 Jan;16(1):22-9. doi: 10.1111/dom.12173. Epub 2013 Jul 19.

PMID:
23802997
47.

Evaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure data.

Gamble JM, Johnson JA, Majumdar SR, McAlister FA, Simpson SH, Eurich DT.

Pharmacoepidemiol Drug Saf. 2013 May;22(5):551-5. doi: 10.1002/pds.3427. Epub 2013 Mar 8.

PMID:
23475736
48.

An optically actuated surface scanning probe.

Phillips DB, Gibson GM, Bowman R, Padgett MJ, Hanna S, Carberry DM, Miles MJ, Simpson SH.

Opt Express. 2012 Dec 31;20(28):29679-93. doi: 10.1364/OE.20.029679.

PMID:
23388796
49.

Adding pharmacists to primary care teams increases guideline-concordant antiplatelet use in patients with type 2 diabetes: results from a randomized trial.

Gilani F, Majumdar SR, Johnson JA, Tsuyuki RT, Lewanczuk RZ, Spooner R, Simpson SH.

Ann Pharmacother. 2013 Jan;47(1):43-8. doi: 10.1345/aph.1R552. Epub 2013 Jan 16.

PMID:
23324512
50.

A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the world health organization multidimensional adherence model.

AlGhurair SA, Hughes CA, Simpson SH, Guirguis LM.

J Clin Hypertens (Greenwich). 2012 Dec;14(12):877-86. doi: 10.1111/j.1751-7176.2012.00699.x. Epub 2012 Aug 20. Review.

Supplemental Content

Loading ...
Support Center